COVID still a killer for 500,000 vulnerable people – but Thailand has new defense

Thailand is strengthening its defenses against COVID-19 for about 500,000 immunocompromised people who – vaccinated or otherwise – remain vulnerable. This extra protection comes in the form of AstraZeneca’s long-acting…

Read More

Thai Health Ministry starts trial of LAAB drug in immunocompromised patients

The Thai Ministry of Public Health has started administering a Long Acting Antibody (LAAB) treatment to three patients suffering from chronic kidney disease, to boost their immunity against COVID-19 infection,…

Read More

Long-Acting Antibody treatment to be provided to those suffering immunodeficiency

Thailand’s Ministry of Public Health and AstraZeneca (Thailand) signed a contract today (Wednesday) for the procurement of 257,500 doses of Long-Acting Antibodies (LAAB) for people who suffer from immunodeficiency, to…

Read More

Page 1 of 1


Welcome! Login in to your account

Remember me Lost your password?

Lost Password